Tevogen (TVGN) Current Leases (2023 - 2026)
Tevogen Bio Holdings' (TVGN) quarterly Current Leases came in at $327740.0 in Q1 2026, up 91.83% YoY from $170851.0 in Q1 2025, and little changed on a QoQ basis from $327740.0 in Q4 2025.
Tevogen (TVGN) Current Leases (2023 - 2026) Analysis & Trends
Tevogen Bio Holdings (TVGN) has 4 years of Current Leases data on file, last reported at $327740.0 in Q1 2026.
- Quarterly Current Leases rose 91.83% year-over-year to $327740.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $327740.0 (up 91.83% YoY) and the FY2025 annual result came in at $327740.0, up 43.08% from the prior year.
- Current Leases steadied at $327740.0 in Q1 2026, from $327740.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $327740.0 in Q2 2025 to a low of $170851.0 in Q1 2025.
- A 4-year average of $275135.0 and a median of $264627.5 in 2024 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2025 — Current Leases plunged 34.44% — and 2026, when it jumped 91.83%.
- Tracing TVGN's Current Leases over 4 years: stood at $252714.0 in 2023, then slipped by 9.36% to $229063.0 in 2024, then surged by 43.08% to $327740.0 in 2025, then changed by 0.0% to $327740.0 in 2026.
- The last three Current Leases figures came in at $327740.0 (Q1 2026), $327740.0 (Q4 2025), and $327740.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.66 Bn | 131.81 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.52 Bn | 78.52 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 65.30 Bn | 60.11 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.18 Bn | 54.04 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.08 Bn | 36.98 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 31.77 Bn | 28.46 Bn | 992.69 Mn | 45.93 Mn |
| 7 | BioNTech SE | 28.13 Bn | 9.74 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn | 6.27 Mn |
| 9 | Royalty Pharma | 27.16 Bn | 26.32 Bn | - | - |
| 10 | Tevogen | 26.21 Mn | 26.21 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 327,740.00 |
| Dec 31, 2025 | 327,740.00 |
| Sep 30, 2025 | 327,740.00 |
| Jun 30, 2025 | 327,740.00 |
| Mar 31, 2025 | 170,851.00 |
| Dec 31, 2024 | 229,063.00 |
| Sep 30, 2024 | 258,507.00 |
| Jun 30, 2024 | 268,672.00 |
| Mar 31, 2024 | 260,583.00 |
| Dec 31, 2023 | 252,714.00 |